L’hôpital de Hautepierre est un centre hospitalier universitaire situé à Strasbourg, dans le quartier de Hautepierre. Il est rattaché aux Hôpitaux universitaires de Strasbourg. Ouvert en 1979, il compte 916 lits.

During the past decade, Hopital de Hautepierre conducted 146 clinical trials. In the 10-year time frame, 146 clinical trials started and 39 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 24 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de Hautepierre" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Celgene" with 9 trials sponsored, "Ipsen" with 8 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 8 trials sponsored. Other sponsors include 199 different institutions and companies that sponsored additional 122 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de Hautepierre" #1 collaborator was "Ministry of Health, France" with 12 trials as a collaborator, "Celgene Corporation" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 3 trials as a collaborator, "National Cancer Institute, France" with 3 trials as a collaborator and "Roche Pharma AG" with 3 trials as a collaborator. Other collaborators include 117 different institutions and companies that were collaborators in the rest 114 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de Hautepierre" are "Rheumatoid Arthritis" (7 trials), "Leukemia" (5 trials), "Myelodysplastic Syndromes" (5 trials), "Alzheimer Disease" (4 trials) and "Critical Illness" (4 trials). Many other conditions were trialed in "Hopital de Hautepierre" in a lesser frequency.

Most popular intervention types in "Hopital de Hautepierre" are "Drug" (167 trials), "Other" (35 trials), "Procedure" (27 trials), "Biological" (18 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "fluorouracil" (6 trials), "leucovorin calcium" (6 trials), "APD421" (5 trials) and "Lenalidomide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de Hautepierre" are 227 trials for "All" genders, 16 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 67 active trials in "Hopital de Hautepierre". 2 are not yet recruiting, 45 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 144 completed trials in Hopital de Hautepierre, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de Hautepierre, 3 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 40 trials that are defined as “Not Applicable".